CONMED Corporation (NYSE: CNMD) is a Healthcare company (Medical - Devices) with a market capitalization of $1.4B. The Maz Rating grades it against the other companies in its sector.
CONMED Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $48.39, CONMED Corporation trades at 20.1x trailing earnings, 1.1x sales and 1.4x book value, with an EV/EBITDA of 10.5. Over the last twelve months it generated about $1.4B of revenue and $72M of net income. It runs a gross margin of 57.2%, an operating margin of 12.1% and a net margin of 5.4%. It shows return on equity of 7.1%, return on invested capital of 5.7% and a free cash flow yield of 9.2%. On the balance sheet: a debt-to-equity ratio of 0.77 and a current ratio of 1.49. Over the past 52 weeks the share price ranged from $31.44 to $54.80, with a beta of 0.90.
CONMED Corporation does not currently pay a dividend.
21 Wall Street analyst ratings cover the stock: 7 Buy, 13 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.